A new study published in the journal Anesthesiology found that continuous positive airway pressure (CPAP) therapy can potentially reduce postoperative complications in patients undergoing surgery that experience obstructive sleep apnea.1 Sleep apnea is an underreported and under-diagnosed…

Dr. Linda Gray works at our Mesquite, Texas, campus. Linda joined the Carrington family in January this year. Prior to joining us she spent 10 years at Baylor University Medical Center; she worked in administration as a nurse manager for women’s health and gynecology, as well as managing the…

A new study conducted by British researchers found that human papillomavirus can accurately be detected through a simple urine test. HPV, which is the most common sexually transmitted infection, can lead to cervical cancer and other major medical issues. This is good news, for in the past HPV…

If you read part one of our interview with Liza Long, you’ll know she is the manager of the Student Success Center at our Boise, ID, campus.
But Liza came to prominence at a national level after a blog she wrote in the wake of the Newtown shootings went viral. The post, titled “I am Adam Lanza’s…

Hello Carrington College!  Student blogger Chelsea checking in again. If you’ve been following my experiences over the last 6 months I hope they’re helping you on your journey, no matter what campus you’re at or what program you’re studying. Last time I mentioned that once I graduate, we hope…

Our colleague, Liza Long, is manager of the Student Success Center at our Boise, ID, campus. But do a Google search and you’ll discover that, in addition to her “day job” with us, Liza is also a mental health advocate, a published author, and a prominent blogger. You can read more about that…

The Food and Drug Administration has officially greenlit Contrave, a new drug that targets obesity and only one of three such medications to be approved by the organization in the past decade.1 The two other obesity pills, Qsymia and Belviq, were both approved by the FDA in 2012. Both of these…